- Small but consistent clinical trials suggest ashwagandha root extract may modestly improve sleep quality, especially in people with self-reported insomnia or high stress.
- The evidence is promising but limited — most trials are short (6–12 weeks), use different extracts, and involve fewer than 150 participants, so confidence is moderate at best.
- A standardized root extract (KSM-66 or Sensoril) at 300–600 mg/day, taken at night, is the most studied protocol.
- People with thyroid disorders, autoimmune conditions, or who are pregnant should avoid ashwagandha without medical clearance.
What the evidence shows
The honest summary: ashwagandha is one of the more credible herbal options for sleep, but "more credible than most herbs" is still a modest bar. Here is what the controlled trials actually show.
A double-blind, randomized, placebo-controlled trial of 60 adults with insomnia disorder found that 300 mg of ashwagandha root extract (KSM-66) twice daily for 10 weeks significantly improved sleep onset latency, total sleep time, sleep efficiency, and scores on the Pittsburgh Sleep Quality Index (PSQI) compared with placebo (Langade et al., 2019). Waking after sleep onset also decreased. Effect sizes were meaningful, though the sample was small.
A second RCT in 150 healthy adults without a clinical sleep disorder used a lower dose (120 mg of a concentrated root extract) and found statistically significant but numerically smaller improvements in sleep quality and morning alertness at 6 weeks (Deshpande et al., 2020). This matters because it suggests even people without insomnia may see some benefit — but the effect is smaller when you are not starting from a troubled baseline.
A systematic review and meta-analysis pooling five RCTs (total n = 400) concluded that ashwagandha had a small but statistically significant effect on overall sleep quality, sleep onset latency, and anxiety, with the largest benefits in participants who had a diagnosed sleep problem and in trials using doses ≥ 600 mg/day for ≥ 8 weeks (Cheah et al., 2021).
What the evidence does not show: there are no long-term trials (beyond 12 weeks), no head-to-head comparisons with sleep medications or melatonin, and no studies in shift workers, older adults with comorbidities, or adolescents. The trials that exist are largely industry-funded, which is a legitimate reason to temper enthusiasm.
How it works (mechanism)
Ashwagandha (Withania somnifera) is classified as an adaptogen — a compound thought to buffer the body's stress response. Its primary active constituents are withanolides, steroidal lactones that appear to modulate the hypothalamic-pituitary-adrenal (HPA) axis. Chronically elevated cortisol is a well-established disruptor of sleep architecture, particularly slow-wave and REM sleep, so blunting the cortisol stress response is a plausible route to better sleep.
Animal research also points to triethylene glycol — a different component found mainly in ashwagandha leaves — as potentially inducing non-rapid eye movement (NREM) sleep through GABA-receptor activity (Kaushik et al., 2017). Whether this translates meaningfully at human doses of root extract is not yet clear.
There is also a secondary pathway through anxiety reduction. Ashwagandha consistently lowers self-reported anxiety in RCTs (Pratte et al., 2014; Chandrasekhar et al., 2012), and anxiety is among the most common causes of sleep-onset difficulty. So the sleep benefit may be partly — or even largely — an indirect effect of calmer pre-sleep cognition rather than a direct sedative action.
Dose & timing if you try it
Based on the trials with the clearest positive results, here is a reasonable starting protocol:
- Form: Standardized root extract — look for KSM-66 or Sensoril on the label. These are the two proprietary extracts used in most published trials. Generic "ashwagandha powder" capsules without standardization are a reasonable lower-cost option but have less direct evidence behind them.
- Dose: 300–600 mg per day. The Langade et al. (2019) trial used 300 mg twice daily (total 600 mg); the Cheah et al. (2021) meta-analysis found stronger effects at ≥ 600 mg/day.
- Timing: Taking the full dose or the larger half-dose in the evening (1–2 hours before bed) is the most common clinical protocol for sleep, though split dosing (morning and evening) was used in some trials.
- Duration: Allow at least 6–8 weeks before judging whether it is helping. This is not melatonin — it does not sedate you acutely. The effect builds gradually.
- With food: Most trials administered it with meals to improve tolerability and absorption.
Who should skip it
Ashwagandha is not appropriate for everyone:
- Pregnant people: Ashwagandha has been used historically as an abortifacient and is contraindicated in pregnancy. Do not use.
- Breastfeeding people: Safety data are absent; avoid.
- Thyroid conditions: Ashwagandha can increase thyroid hormone levels (T3 and T4). People with hyperthyroidism or those on thyroid medication should speak with their prescriber before use (Sharma et al., 2018).
- Autoimmune diseases: As an immune modulator, it could theoretically stimulate immune activity in conditions like lupus, rheumatoid arthritis, or multiple sclerosis. Evidence is largely theoretical, but the caution is standard.
- Liver disease or elevated liver enzymes: Rare but credible case reports of hepatotoxicity linked to high-dose or prolonged ashwagandha use have appeared in the literature. Anyone with underlying liver problems should avoid it (Björnsson et al., 2020).
- Scheduled surgery: Stop at least two weeks prior, as it may potentiate anesthesia and affect blood pressure.
- Sedative medications: May have additive CNS-depressant effects with benzodiazepines, zolpidem, or anticonvulsants.
Bottom line
Ashwagandha has more and better evidence behind it for sleep than most supplements in this category — which is genuinely useful to know. The effect appears real, particularly for people whose sleep is disrupted by stress or anxiety. That said, the effect is modest, the trials are short and small, and most are funded by manufacturers of the extracts being tested. This is not a replacement for sleep hygiene, cognitive behavioral therapy for insomnia (CBT-I), or medical evaluation of an underlying sleep disorder.
If you want to try it: use a standardized extract, give it two months, and track your sleep with a simple log or wearable so you are not relying on impression alone. If nothing has shifted after eight weeks, stop — your money is better spent elsewhere.
References
- Langade, D., Kanchi, S., Salve, J., Debnath, K., & Ambegaokar, D. (2019). Efficacy and safety of ashwagandha root extract in insomnia and anxiety. Cureus, 11(9), e5797.
- Deshpande, A., Irani, N., Balkrishnan, R., & Benny, I. R. (2020). A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha on sleep quality in healthy adults. Sleep Medicine, 72, 28–36.
- Cheah, K. L., Norhayati, M. N., Husniati Yaacob, L., & Abdul Rahman, R. (2021). Effect of ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLOS ONE, 16(9), e0257843.
- Kaushik, M. K., Kasemsuk, T., Peungvicha, P., Tohda, C., & Urade, Y. (2017). Triethylene glycol, an active component of Ashwagandha (Withania somnifera) leaves, is responsible for sleep induction. PLOS ONE, 12(2), e0172508.
- Chandrasekhar, K., Kapoor, J., & Anishetty, S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262.
- Pratte, M. A., Nanavati, K. B., Young, V., & Morley, C. P. (2014). An alternative treatment for anxiety: A systematic review of human trial results reported for the ayurvedic herb ashwagandha (Withania somnifera). Journal of Alternative and Complementary Medicine, 20(12), 901–908.
- Sharma, A. K., Basu, I., & Singh, S. (2018). Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients. Journal of Alternative and Complementary Medicine, 24(3), 243–248.
- Björnsson, H. K., Björnsson, E. S., et al. (2020). Ashwagandha-induced liver injury: A case series and review. Liver International, 40(4), 825–829.